Comprehensive immunohistological analysis of the endothelin system in human kidney grafts

被引:15
作者
Frank, K
Zeier, M
Gross, ML
Waldherr, R
Ritz, E
Amann, K
机构
[1] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany
[2] Univ Heidelberg, Dept Pathol, D-6900 Heidelberg, Germany
[3] Univ Heidelberg, Dept Internal Med, D-6900 Heidelberg, Germany
[4] Praxis Pathol, Heidelberg, Germany
关键词
acute renal failure; endothelin; endothelin receptor; recurrent glomerulonephritis; transplantation;
D O I
10.1093/ndt/gfk087
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. In experimental models of renal transplantation, upregulation of the endothelin (ET) system and amelioration of renal injury by ET-receptor blockers have been documented. In contrast, little information is available on the expression of the ET system in human kidney allografts. It was the purpose of the present study to analyse by immunohistology the expression of ET-1 as well as of the two ET receptors (ET-RA and ET-RB) in the different cells and compartments of kidney grafts and control kidneys. Methods. Fifty-five graft biopsies were taken from 55 kidney allograft recipients (mean age: 32 +/- 2.8 years) who were all on a calcineurin inhibitor. The indication for biopsies was delayed graft function or suspected rejection. The underlying diagnoses were acute allograft rejection (n = 14), chronic allograft nephropathy (n = 14), cyclosporin A (CSA) toxicity (n = 10), post-operative acute tubular necrosis (ATN) (n = 11) and recurrent primary disease (n = 6). As control, tissues of non-grafted kidneys with ATN (mean age: 35 +/- 24 years), of primary glomerulonephritis (mean age: 69 +/- 10 years) and of non-tumour-bearing parts of eight tumour nephrectomy specimens (mean age: 67 +/- 5 years) were assessed. The biopsies were scored using the 1997 Banff criteria. Expression of ET-1, ET-RA and ET-RB as well as of vascular endothelial growth factor was evaluated by immunohistochemistry and a semi-quantitative scoring system. Interstitial infiltrating cells were characterized using antibodies against T cells, B cells and macrophages (CD3, CD20 and CD68). Results. Control cases showed only faint expression of ET-1 in glomeruli (in podocytes and endothelial cells), whereas marked expression was seen in distal, but less in proximal tubular cells. The interstitium was completely negative. ET-1 expression was seen in vascular endothelial cells (VEC) and vascular smooth muscle cells (VSMC). Only faint expression of ET-RA and ET-RB was found in glomeruli and tubuli (distal more than proximal). Marked ET-RA and ET-RB expression was seen in VEC and VSMC. In all transplanted kidneys, irrespective of the underlying diagnosis, expression of ET-1, ET-RA and ET-RB was markedly higher compared with control kidneys. ET-1 was strikingly upregulated in glomeruli and tubuli, but surprisingly not in the vasculature of grafts with CSA toxicity. Expression of ET-RB was markedly increased in CSA toxicity in glomeruli, tubuli and vessels. In grafts with ATN and acute rejection, pronounced expression of ET-RA was noted. There was a strong correlation between proteinuria and expression of ET-1 in glomeruli and proximal tubuli and of ET-RB in proximal tubuli. Conclusions. The above data in human kidney allograft biopsies are consistent with an important role of the ET system in different types of renal allograft damage. This finding extends and clarifies the somewhat contradictory results in animal models.
引用
收藏
页码:1365 / 1372
页数:8
相关论文
共 16 条
[1]   Combination treatment with an ETA-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model [J].
Adams, J ;
Odoni, G ;
Ogata, H ;
Viedt, C ;
Amann, K ;
Ritz, E ;
Orth, SR .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (05) :780-787
[2]   Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist [J].
Braun, C ;
Conzelmann, T ;
Vetter, S ;
Schaub, M ;
Back, WE ;
Yard, B ;
Kirchengast, M ;
Tullius, SG ;
Schnülle, P ;
van der Woude, FJ ;
Rohmeiss, P .
TRANSPLANTATION, 1999, 68 (06) :739-746
[3]   Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats [J].
Braun, C ;
Conzelmann, T ;
Vetter, S ;
Schaub, M ;
Back, WE ;
Kirchengast, M ;
Tullius, SG ;
Schnülle, P ;
van der Woude, FJ ;
Rohmeiss, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (04) :428-437
[4]   Elevated endothelin-1 in tubular epithelium is associated with renal allograft rejection [J].
Chareandee, C ;
Herman, WH ;
Hricik, DE ;
Simonson, MS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :541-549
[5]   Endothelin-1, endothelin-3 and their receptors (endothelin, and endothelinB) in chronic renal transplant rejection in rats [J].
Deng, DX ;
Jiang, JF ;
Garcia, B ;
Zhong, R ;
Chakrabarti, S .
TRANSPLANT INTERNATIONAL, 2000, 13 (03) :175-182
[6]   Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection [J].
Knoll, T ;
Oltersdorf, J ;
Göttmann, U ;
Schaub, M ;
Michel, MS ;
Kirchengast, M ;
van der Woude, FJ ;
Rohmeiss, P ;
Braun, C .
TRANSPLANT INTERNATIONAL, 2003, 16 (06) :425-429
[7]  
Lehrke I, 2001, J AM SOC NEPHROL, V12, P2321, DOI 10.1681/ASN.V12112321
[8]  
Murer L, 1997, J NEPHROL, V10, P318
[9]  
Orth SR, 1999, J AM SOC NEPHROL, V10, P387
[10]   Combination treatment with an ETA-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models [J].
Orth, SR ;
Odoni, G ;
Karkoszka, H ;
Ogata, H ;
Viedt, C ;
Amann, K ;
Ferrari, P ;
Ritz, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (01) :62-69